Supplementary Data from Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor

Authors :: Irwin Hollander
Aranapakam Venkatesan
Semiramis Ayral-Kaloustian
Osvaldo dos Santos
Zecheng Chen
Efren Delos Santos
Christoph Dehnhardt
Inder Chaudhary
Judy Lucas
Larry R. Feldberg
Robert Mallon
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figures S1-S10; Supplementary Tables S1-S5.

Tools